# Lubiprostone for Chronic Idiopathic Constipation Treatment

> **NCT02729909** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 211 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Lubiprostone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02729909
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-11
- **Primary completion:** 2017-04-28
- **Final completion:** 2017-06-05
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729909, "Lubiprostone for Chronic Idiopathic Constipation Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02729909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*